News for PFIZER INC (PFED.BA)

Published at

Jul 11, 2025 1:57 PM

by benzinga.com

mixed

mixed

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - AbbVie (NYSE:ABBV), Amgen (NASDAQ:AMGN)

Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to

VERV JNJ DJNJ3.BA DJNJ2.BA REGN34.SA REGN.MX REGN PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRKD.BA MRK.SN MRK.PA MRK.MX MRK GIS.DE GILDD.BA GILD.MX GILD AMGN.MX AMGN.BA AMGN AMG.DE ABBV34.SA ABBV.MX ABBV.BA ABBV 6MK.DE 4AB.DE 0R2M.L AMZNCL.SN AMZN.SN AMZN.MX AMZN AMZ.DE

Read more →
Published at

Jul 11, 2025 7:00 AM

by insurancejournal.com

neutral

neutral

Delaware Top Court Sides With Zantac Makers in Cancer Claims

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 10, 2025 11:00 PM

by gurufocus.com

mixed

mixed

Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company's transformation and growth in a

VOR SRPT PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE CRSP

Read more →
Published at

Jul 10, 2025 3:58 PM

by gurufocus.com

positive

positive

Pfizer (PFE) and BioNTech Appeal Patent Ruling Favoring Moderna

Key Takeaways: Pfizer and BioNTech are contesting a UK court ruling favoring Moderna's vaccine patent. Analysts predict a potential 12.15% upside for Pfi

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 10, 2025 2:18 PM

by gurufocus.com

positive

positive

Pfizer (PFE) Announces Positive Results from Prostate Cancer Drug Study | PFE Stock News

Pfizer (PFE) has reported promising top-line findings from the Phase 3 EMBARK study, which examined the effectiveness of xtandi, also known as enzalutamide, bot

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 10, 2025 2:00 PM

by gurufocus.com

mixed

mixed

XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence | PFE Stock News

XTANDI® plus leuprolide significantly improves overall survival in non-metastatic hormone-sensitive prostate cancer. The Phase 3 EMBARK study shows a m

ALPMY ALPMF 4503N.MX PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 10, 2025 2:00 PM

by gurufocus.com

mixed

mixed

XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the ov

ALPMY ALPMF 4503N.MX PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 9, 2025 10:10 PM

by manilatimes.net

mixed

mixed

Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM)

PFED.BA PFECL.SN PFE.MX PFE.DE PFE GIS.DE GILDD.BA GILD.MX GILD NRIX

Read more →
Published at

Jul 9, 2025 6:12 PM

by finance.yahoo.com

positive

positive

Pfizer Earnings Preview: What to Expect

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company’s bottom-line figure.

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 9, 2025 5:17 PM

by insurancejournal.com

positive

positive

Trump Vows No Tariff Extension, Hardens Threats on Copper, Drugs

President Donald Trump vowed to push forward with his aggressive tariff regime in the coming days, stressing he would not offer additional extensions on

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 9, 2025 7:37 AM

by raskmedia.com.au

mixed

mixed

How Aussies invest on the New York Stock Exchange (NYSE)

How do Aussies invest on the New York Stock Exchange (NYSE) and buy shares of companies like Microsoft (NASDAQ: MSFT) and Visa (NYSE: V)?

WMTD.BA WMTC.BA WMT.SN WMT.MX WMT.DE WMT WDP.DE WALMARTCL.SN VISA34.SA VD.BA VCL.SN VC.BA V.SW V.SN V.MX V.BA V PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NKED.BA NKECL.SN NKE.SN NKE.MX NKE.DE NKE.BA NKE KO.SN KO.MX KO JPMML JPM GPN DISCL.SN DISB34.SA DIS.SN DIS.MX DIS CSL.AX COCA34.SA CCC3.DE BHP.AX BHP BBL 3V64.DE MSFT JPMCL.SN JPMC.BA JNJ DJNJ3.BA DJNJ2.BA AAPL

Read more →
Published at

Jul 7, 2025 2:00 PM

by gurufocus.com

mixed

mixed

European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia

Regulatory momentum builds for bexobrutideg with multiple designations across the United States and EU, Including EMA PRIME and FDA Fast Track for CLL/SLL SAN

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE GIS.DE GILDD.BA GILD.MX GILD NRIX

Read more →
Published at

Jul 3, 2025 3:53 PM

by seekingalpha.com

positive

positive

Pfizer: Options Activity Speaks Bullish (NYSE:PFE)

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my updated look at PFE stock prospects.

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 3, 2025 2:03 PM

by benzinga.com

mixed

mixed

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - CVS Health (NYSE:CVS), Merck & Co (NYSE:MRK)

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE CVSH34.SA CVSCL.SN CVS.SN CVS.MX CVS.DE CVS 0HRS.L MRKD.BA MRK.SN MRK.PA MRK.MX MRK 6MK.DE

Read more →
Published at

Jul 3, 2025 11:27 AM

by fortune.com

mixed

mixed

New London IPOs hit 28-year low amid AstraZeneca exit concerns

More than $100 billion worth of London-listed companies have announced or executed plans to move to New York in recent years.

WPLCF SMDS.L PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE PDYPY PDYPF IZQVF INVVY INDV.L FLTR.L DITHF CRHCF CRH.L CRH CRG.IR SXS.L SEPJY SEPJF ROO.L GLNCY GLN.JO GLENN.MX GLEN.L GLCNF DROOF ARSSF AGR.L 0IVW.L BNPQY BNPQF BNPN.MX BNP.PA BNP.MI BNP.DE

Read more →
Published at

Jul 2, 2025 10:55 PM

by gurufocus.com

positive

positive

CDC Endorsement Boosts Pfizer (PFE) in RSV Vaccine Market

Summary: The CDC's approval of Pfizer's RSV vaccine for adults aged 50-59 strengthens Pfizer's market position. Analysts predict moderate upside potentia

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRNA GSK

Read more →
Published at

Jul 1, 2025 3:00 PM

by zacks.com

neutral

neutral

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →
Published at

Jul 1, 2025 2:29 PM

by manilatimes.net

mixed

mixed

Esperion Appoints Craig Thompson to Board of Directors

Brings More Than Twenty Years of Biopharmaceutical Leadership Experience

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NGENF NGEN.V ESPR 0IIM.L ANTH

Read more →
Published at

Jun 30, 2025 8:28 PM

by forbes.com

mixed

mixed

5 Best Undervalued Stocks To Buy For July 2025

Looking for undervalued stocks? We identified the top undervalued stocks in July 2025. Check out the list here.

JNJ INTC.SN INTC.MX INTC INL.DE INCO.BR DJNJ3.BA DJNJ2.BA BRKBD.BA BRKBB.BA BRKB.BA PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE KO.SN KO.MX KO COCA34.SA CCC3.DE

Read more →
Published at

Jun 28, 2025 10:16 AM

by finance.yahoo.com

mixed

mixed

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the most undervalued US stocks according to analysts. On June 20, Lantheus Holdings announced its participation in the newly launched FIBRE Consortium, which is a collaborative initiative with Pfizer Inc. (NYSE:PFE) and Lumina Pharmaceuticals. The consortium’s primary goal is to revolutionize the treatment of fibrotic diseases by using […]

LNTH PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE

Read more →